royal society of medicine - medical innovations - kit yamoyo and its value chain
TRANSCRIPT
![Page 1: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/1.jpg)
Medical Innovations – Kit Yamoyo and its value chain
11th Medical Innovations Summit 2015, Royal Society of Medicine 12-Sep-15
#medinnov@colalife
Simon Berry
![Page 2: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/2.jpg)
![Page 3: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/3.jpg)
What is ColaLife and who are we?
ColaLife is a charity registered in the UKCharity number: 1142516
• Two founding executives• Five voluntary trustees• Focus on saving children’s lives• Independent• Our only project is in Zambia• Looking for global impact through
• Disruptive innovation• Generating robust evidence• Sharing findings and learning
• No personal commercial interest
![Page 4: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/4.jpg)
Rohit Ramchandani
Jane Berry
The other members of the ColaLife team
![Page 5: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/5.jpg)
Our starting point
What we did next
1
Next moves
What we did What we learned
2 3
54
Medical Innovations – Kit Yamoyo and its value chain
11th Medical Innovations Summit 2015, Royal Society of Medicine 12-Sep-15
![Page 6: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/6.jpg)
Our starting point
What we did next
1
Next moves
What we did What we learned
Medical Innovations – Kit Yamoyo and its value chain
11th Medical Innovations Summit 2015, Royal Society of Medicine 12-Sep-15
2 3
54
![Page 7: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/7.jpg)
observation 1
![Page 8: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/8.jpg)
![Page 9: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/9.jpg)
![Page 10: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/10.jpg)
![Page 11: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/11.jpg)
![Page 12: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/12.jpg)
Diarrhoea
17%
Malaria
12%
AIDS
3%
Diarrhoea kills more children than Malaria and AIDS combined
![Page 13: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/13.jpg)
In Zambia 46% of children are stunted (up to 70% in some areas)
![Page 14: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/14.jpg)
observation 2
![Page 15: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/15.jpg)
![Page 16: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/16.jpg)
Full shopsFull shops – empty clinics
Remote rural retail shop, Kalomo District, Zambia
Drug store room, Tiriri Health Centre, Katine, Uganda
![Page 17: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/17.jpg)
the idea
![Page 18: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/18.jpg)
Why not put ORS & Zinc Kit in Coca-Cola crates?
![Page 19: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/19.jpg)
Our starting point
What we did next Next moves
What we did What we learned
Medical Innovations – Kit Yamoyo and its value chain
11th Medical Innovations Summit 2015, Royal Society of Medicine 12-Sep-15
2 3
54
1
![Page 20: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/20.jpg)
Jun 2010 | Gave up jobs to try and get a trial started
![Page 21: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/21.jpg)
Jun 2010 | Gave up jobs to try and get a trial started
Our kitchen tableUK
![Page 22: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/22.jpg)
Jun 2010 | Gave up jobs to try and get a trial started
Rohit on SkypeCanada
Our kitchen tableUK
![Page 23: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/23.jpg)
Jun 2010 | Gave up jobs to try and get a trial started
Rohit on SkypeCanada
Harvard & UNICEF on speaker phoneUSA
Our kitchen tableUK
![Page 24: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/24.jpg)
Sep 2010 | Cycle ride across France raised £6,000
![Page 25: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/25.jpg)
Oct 2010 | First of three consultation trips to Zambia
![Page 26: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/26.jpg)
Jun 2011 | Partnership and trial plan in place
![Page 27: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/27.jpg)
impactMothers in underserved rural communities increase use of ORS and Zinc in home treatment of diarrhoea
purposeTarget communities in two under-served rural districts have improved access to ORS and Zinc
outputs
Profit-driven supply chains improve availability of ADKs (anti-diarrhoea kits) in targeted communities in two underserved rural districts
Mothers/care-givers demonstrate awareness of ADKs and the benefits of the contents (ORS, Zinc and Soap)
access = ADK in the hand of an aware mother/care-giver
Availability = ADK in stock in retail outlets at community level
Generating robust evidence - the COTZ results framework
![Page 28: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/28.jpg)
Dec 2011
COTZ trial timeline | 24 months
![Page 29: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/29.jpg)
Our starting point
What we did next Next moves
What we did What we learned
Medical Innovations – Kit Yamoyo and its value chain
11th Medical Innovations Summit 2015, Royal Society of Medicine 12-Sep-15
2 3
54
1
![Page 30: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/30.jpg)
Early 2012 | Pre-trial focus group work
What we learnt
Litre sachets are too big
Measuring water was an issue
Willingness to pay
Preferred branding
![Page 31: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/31.jpg)
Mar 2012 | Finalised the Kit Yamoyo design
![Page 32: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/32.jpg)
Mar 2012 | Finalised the Kit Yamoyo design
Kit Yamoyo• Attractive
![Page 33: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/33.jpg)
Mar 2012 | Finalised the Kit Yamoyo design
Kit Yamoyo• Attractive
• ORS sachets are 200ml
![Page 34: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/34.jpg)
Mar 2012 | Finalised the Kit Yamoyo design
Kit Yamoyo• Attractive
• ORS sachets are 200ml
• Packaging is also:
• A measuring device for
the water
![Page 35: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/35.jpg)
Mar 2012 | Finalised the Kit Yamoyo design
Kit Yamoyo• Attractive
• ORS sachets are 200ml
• Packaging is also:
• A measuring device for
the water
• A mixing device
![Page 36: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/36.jpg)
Mar 2012 | Finalised the Kit Yamoyo design
Kit Yamoyo• Attractive
• ORS sachets are 200ml
• Packaging is also:
• A measuring device for
the water
• A mixing device
• A storage device (the
soap tray is a lid)
• A cup
![Page 37: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/37.jpg)
![Page 38: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/38.jpg)
Awards | The Kit Yamoyo has won many global awards
![Page 39: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/39.jpg)
0Nobody sold ORS or Zinc in the private sector.
Sep 2012
Before we started
![Page 40: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/40.jpg)
0Nobody sold ORS or Zinc in the private sector.
<1%of children received the correct treatment for diarrhoea
Sep 2012
Before we started
![Page 41: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/41.jpg)
0Nobody sold ORS or Zinc in the private sector.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
Sep 2012
Before we started
![Page 42: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/42.jpg)
60%Only 60% of mothers mixed ORS correctly when given litre sachets.
0Nobody sold ORS or Zinc in the private sector.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
Sep 2012
Before we started
![Page 43: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/43.jpg)
60%Only 60% of mothers mixed ORS correctly when given litre sachets.
0Nobody sold ORS or Zinc in the private sector.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
Sep 2012
Before we started
![Page 44: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/44.jpg)
60%Only 60% of mothers mixed ORS correctly when given litre sachets.
0Nobody sold ORS or Zinc in the private sector.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
Aug 2013
After 12 months
Sep 2012
Before we started
![Page 45: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/45.jpg)
60%Only 60% of mothers mixed ORS correctly when given litre sachets.
0Nobody sold ORS or Zinc in the private sector.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/from Zinc. Up a baseline of <1%.
Aug 2013
After 12 months
Sep 2012
Before we started
![Page 46: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/46.jpg)
60%Only 60% of mothers mixed ORS correctly when given litre sachets.
0Nobody sold ORS or Zinc in the private sector.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/from Zinc. Up a baseline of <1%.
2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.
Aug 2013
After 12 months
Sep 2012
Before we started
![Page 47: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/47.jpg)
60%Only 60% of mothers mixed ORS correctly when given litre sachets.
0Nobody sold ORS or Zinc in the private sector.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/from Zinc. Up a baseline of <1%.
2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.
93%of Kit Yamoyo users mixed ORS correctly. Only 60% do when given 1 litre sachets.
Aug 2013
After 12 months
Sep 2012
Before we started
![Page 48: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/48.jpg)
60%Only 60% of mothers mixed ORS correctly when given litre sachets.
0Nobody sold ORS or Zinc in the private sector.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/from Zinc. Up a baseline of <1%.
2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.
93%of Kit Yamoyo users mixed ORS correctly. Only 60% do when given 1 litre sachets.
Aug 2013
After 12 months
Sep 2012
Before we started
![Page 49: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/49.jpg)
4%Only 4% of kits went into Coca-Cola crates.
Aug 2013
After 12 months
![Page 50: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/50.jpg)
In Zambia, it’s the space in the market, not the space in the crates that is important.
This means we can revisit the packaging to make it cheaper.
Kit Yamoyo
Washing Powder
Eggs
Biscuits
Cola – but not Coca-Cola
Bread
![Page 51: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/51.jpg)
Manufacture
Assembly
Distribution
WholesaleK3.10
RetailK3.70
CustomerK5.00
Market development - the Value Chain
![Page 52: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/52.jpg)
Our starting point
What we did next Next moves
What we did What we learned
Medical Innovations – Kit Yamoyo and its value chain
11th Medical Innovations Summit 2015, Royal Society of Medicine 12-Sep-15
2 3
54
1
![Page 53: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/53.jpg)
2014Incorporating the learning
into a national scale-up plan
![Page 54: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/54.jpg)
Control
Trial – 2012-13
Transition – from 2013
Transition
Intervention
Progress towards national coverage
![Page 55: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/55.jpg)
ORS
Reduce number of sachets to 4
NOTE: This will also enhance adherence
Zinc
Produce locally
Only include blister pack
Soap
Produce locally
Leaflet Packaging
Removeconstraint of fitting in Coca-Cola crate
Produce locally
Produce re-fill option
Learning – product design
![Page 56: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/56.jpg)
ORS
Reduce number of sachets to 4
NOTE: This will also enhance adherence
Zinc
Produce locally
Only include blister pack
Soap
Produce locally
Leaflet Packaging
Removeconstraint of fitting in Coca-Cola crate
Produce locally
Produce re-fill option
Learning – product design
![Page 57: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/57.jpg)
4Learning – 200ml ORS sachets
![Page 58: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/58.jpg)
ORS
Reduce number of sachets to 4
NOTE: This will also enhance adherence
Zinc
Produce locally
Only include blister pack
Soap
Produce locally
Leaflet Packaging
Removeconstraint of fitting in Coca-Cola crate
Produce locally
Produce re-fill option
4Learning – reduce number of ORS sachets to 4
![Page 59: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/59.jpg)
ORS
Reduce number of sachets to 4
NOTE: This will also enhance adherence
Zinc
Produce locally
Only include blister pack
Soap
Produce locally
Leaflet Packaging
Removeconstraint of fitting in Coca-Cola crate
Produce locally
Produce re-fill option
4Learning – zinc
![Page 60: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/60.jpg)
Learning - designing for better zinc adherence
![Page 61: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/61.jpg)
ORS
Reduce number of sachets to 4
NOTE: This will also enhance adherence
Zinc
Produce locally
Design the blister pack to enhance adherence to the 10-day regime
Blister pack needs no box
Soap
Produce locally
Leaflet Packaging
Removeconstraint of fitting in Coca-Cola crate
Produce locally
Produce re-fill option
4Learning – zinc packaging design
![Page 62: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/62.jpg)
ORS
Reduce number of sachets to 4
NOTE: This will also enhance adherence
Zinc
Produce locally
Design the blister pack to enhance adherence to the 10-day regime
Blister pack needs no box
Soap
Produce locally
Leaflet Packaging
Removeconstraint of fitting in Coca-Cola crate
Produce locally
Produce re-fill option
4Learning – soap
![Page 63: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/63.jpg)
ORS
Reduce number of sachets to 4
NOTE: This will also enhance adherence
Zinc
Produce locally
Design the blister pack to enhance adherence to the 10-day regime
Blister pack needs no box
Soap
Produce locally(still to be achieved)
Leaflet Packaging
Removeconstraint of fitting in Coca-Cola crate
Produce locally
Produce re-fill option
4Learning – soap
![Page 64: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/64.jpg)
ORS
Reduce number of sachets to 4
NOTE: This will also enhance adherence
Zinc
Produce locally
Design the blister pack to enhance adherence to the 10-day regime
lister pack needs no box
Soap
Produce locally
Leaflet Packaging
Removeconstraint of fitting in Coca-Cola crate
Produce locally
Produce re-fill option
4Learning – leaflet
![Page 65: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/65.jpg)
4Learning – leaflet
![Page 66: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/66.jpg)
ORS
Reduce number of sachets to 4
NOTE: This will also enhance adherence
Zinc
Produce locally
Design the blister pack to enhance adherence to the 10-day regime
Blister pack needs no box
Soap
Produce locally
Leaflet
Simplify –single fold.Same leaflet for all formats
Packaging
4Learning – packaging
![Page 67: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/67.jpg)
ORS
Reduce number of sachets to 4
NOTE: This will also enhance adherence
Zinc
Produce locally
Design the blister pack to enhance adherence to the 10-day regime
Blister pack needs no box
Soap
Produce locally
Leaflet
Simplify –single fold.Same leaflet for all formats
Packaging
Removeconstraint of fitting in Coca-Cola crate. Only 4% of retailers used this option
Produce locally
Produce re-fill option
42014 | Incorporating the learning into the scale-up
![Page 68: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/68.jpg)
4Learning – packaging – the screw-top
![Page 69: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/69.jpg)
4Learning – packaging – the screw-top
![Page 70: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/70.jpg)
4Learning – packaging – the flexi-pack
![Page 71: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/71.jpg)
2015Implementing national
scale-up plans
![Page 72: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/72.jpg)
Scale-up – from 2015
Control
Trial – 2012-13
Transition – from 2013
Transition
Intervention
KYTS-ACE
Progress towards national coverage
![Page 73: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/73.jpg)
452,000
Product - new public sector format
![Page 74: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/74.jpg)
Promotion – aspirational product
![Page 75: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/75.jpg)
Promotion – frontline and face to face
![Page 76: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/76.jpg)
Para-skilling shop-keepers to advise customers
![Page 77: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/77.jpg)
Our starting point
What we did next Next moves
What we did What we learned
Medical Innovations – Kit Yamoyo and its value chain
11th Medical Innovations Summit 2015, Royal Society of Medicine 12-Sep-15
2 3
54
1
![Page 78: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/78.jpg)
Scale-up – from 2015
Control
KYTS-LUSAKA
Trial – 2012-13
Transition – from 2013
Transition
Intervention
KYTS-ACE
Progress towards national coverage
![Page 79: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/79.jpg)
Sharing the learning – our global impact strategy
colalife.org/openaccess
![Page 80: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/80.jpg)
Campaigning for…
1. 200ml ORS sachets for home use2. Co-packaging of ORS and Zinc3. ORS and Zinc as over the counter
medicines4. People to understand that all our
designs, learning and findings are theirs to take and use for FREE – we are NOT promoting a product – we promoting a game-changing new approach to diarrhoea treatment in the home
![Page 81: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/81.jpg)
Chimtende, Katete
Like us on Facebook (please):
facebook.com/colalife
![Page 82: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/82.jpg)
Thank you to the ColaLife funders
Isenberg Family Charitable Foundation
![Page 84: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/84.jpg)
The data contained in this presentation are unpublished and based on preliminary analysis of data from the ColaLife Operational Trial in Zambia (COTZ). Final calculations may vary and will be published in peer reviewed literature in due course.
In the interim, the following citation may be used: Ramchandani, R. et al. (forthcoming). ColaLife Operational Trial Zambia (COTZ) Evaluation. Johns Hopkins Bloomberg School of Public Health, Baltimore.
Related correspondence should be sent to Rohit Ramchandani ([email protected]) and copied to Simon Berry ([email protected]).
A note on the data contained within this presentation
![Page 85: Royal Society of Medicine - Medical Innovations - Kit Yamoyo and its value chain](https://reader034.vdocument.in/reader034/viewer/2022052117/589f220c1a28ab7b208b6495/html5/thumbnails/85.jpg)